BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25951367)

  • 1. Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer.
    Nadolny C; Dong X
    Cancer Biol Ther; 2015; 16(7):997-1004. PubMed ID: 25951367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional overexpression of liver receptor homolog-1 in female mouse mammary epithelium results in altered mammary morphogenesis via the induction of TGF-β.
    Lazarus KA; Brown KA; Young MJ; Zhao Z; Coulson RS; Chand AL; Clyne CD
    Endocrinology; 2014 May; 155(5):1606-17. PubMed ID: 24564400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based discovery of antagonists of nuclear receptor LRH-1.
    Benod C; Carlsson J; Uthayaruban R; Hwang P; Irwin JJ; Doak AK; Shoichet BK; Sablin EP; Fletterick RJ
    J Biol Chem; 2013 Jul; 288(27):19830-44. PubMed ID: 23667258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation.
    Benod C; Vinogradova MV; Jouravel N; Kim GE; Fletterick RJ; Sablin EP
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):16927-31. PubMed ID: 21949357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells.
    Thiruchelvam PT; Lai CF; Hua H; Thomas RS; Hurtado A; Hudson W; Bayly AR; Kyle FJ; Periyasamy M; Photiou A; Spivey AC; Ortlund EA; Whitby RJ; Carroll JS; Coombes RC; Buluwela L; Ali S
    Breast Cancer Res Treat; 2011 Jun; 127(2):385-96. PubMed ID: 20607599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRH-1 (liver receptor homolog-1) derived affinity peptide ligand to inhibit interactions between β-catenin and LRH-1 in pancreatic cancer cells: from computational design to experimental validation.
    Pouraghajan K; Mahdiuni H; Ghobadi S; Khodarahmi R
    J Biomol Struct Dyn; 2022 Apr; 40(7):3082-3097. PubMed ID: 33183172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion.
    Chand AL; Herridge KA; Thompson EW; Clyne CD
    Endocr Relat Cancer; 2010 Dec; 17(4):965-75. PubMed ID: 20817789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing LRH-1 in colon cancer cell lines impairs proliferation and alters gene expression programs.
    Bayrer JR; Mukkamala S; Sablin EP; Webb P; Fletterick RJ
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2467-72. PubMed ID: 25675535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene.
    Annicotte JS; Chavey C; Servant N; Teyssier J; Bardin A; Licznar A; Badia E; Pujol P; Vignon F; Maudelonde T; Lazennec G; Cavailles V; Fajas L
    Oncogene; 2005 Dec; 24(55):8167-75. PubMed ID: 16091743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-136 inhibits colon cancer cell proliferation and invasion through targeting liver receptor homolog-1/Wnt signaling.
    Yuan Q; Cao G; Li J; Zhang Y; Yang W
    Gene; 2017 Sep; 628():48-55. PubMed ID: 28710032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-374b reduces the proliferation and invasion of colon cancer cells by regulation of LRH-1/Wnt signaling.
    Qu R; Hao S; Jin X; Shi G; Yu Q; Tong X; Guo D
    Gene; 2018 Feb; 642():354-361. PubMed ID: 29128635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a new class of liver receptor homolog-1 (LRH-1) antagonists: virtual screening, synthesis and biological evaluation.
    Rey J; Hu H; Kyle F; Lai CF; Buluwela L; Coombes RC; Ortlund EA; Ali S; Snyder JP; Barrett AG
    ChemMedChem; 2012 Nov; 7(11):1909-14. PubMed ID: 22961990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferation activity of a small molecule repressor of liver receptor homolog 1.
    Corzo CA; Mari Y; Chang MR; Khan T; Kuruvilla D; Nuhant P; Kumar N; West GM; Duckett DR; Roush WR; Griffin PR
    Mol Pharmacol; 2015 Feb; 87(2):296-304. PubMed ID: 25473120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of Liver Receptor Homolog-1 modulators.
    Lazarus KA; Wijayakumara D; Chand AL; Simpson ER; Clyne CD
    J Steroid Biochem Mol Biol; 2012 Jul; 130(3-5):138-46. PubMed ID: 22266285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Orphan Nuclear Receptors Steroidogenic Factor-1 and Liver Receptor Homolog-1: Structure, Regulation, and Essential Roles in Mammalian Reproduction.
    Meinsohn MC; Smith OE; Bertolin K; Murphy BD
    Physiol Rev; 2019 Apr; 99(2):1249-1279. PubMed ID: 30810078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression.
    Bianco S; Jangal M; Garneau D; Gévry N
    Oncogene; 2015 Aug; 34(34):4509-18. PubMed ID: 25435372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear-mitochondrial crosstalk: On the role of the nuclear receptor liver receptor homolog-1 (NR5A2) in the regulation of mitochondrial metabolism, cell survival, and cancer.
    Michalek S; Brunner T
    IUBMB Life; 2021 Mar; 73(3):592-610. PubMed ID: 32931651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of liver receptor homolog-1 by microRNA-451 represses the proliferation of osteosarcoma cells.
    Li Z; Wu S; Lv S; Wang H; Wang Y; Guo Q
    Biochem Biophys Res Commun; 2015 Jun; 461(3):450-5. PubMed ID: 25869073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific regulation of aromatase promoter II by the orphan nuclear receptor LRH-1 in breast adipose stromal fibroblasts.
    Chand AL; Herridge KA; Howard TL; Simpson ER; Clyne CD
    Steroids; 2011 Jul; 76(8):741-4. PubMed ID: 21392518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct nuclear receptor expression in stroma adjacent to breast tumors.
    Knower KC; Chand AL; Eriksson N; Takagi K; Miki Y; Sasano H; Visvader JE; Lindeman GJ; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Graham J; Muscat GE; Clarke CL; Clyne CD
    Breast Cancer Res Treat; 2013 Nov; 142(1):211-23. PubMed ID: 24122391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.